A Registry for the Collection of Biological and Clinical Data for Studies of Immune System Related Blood Disorders
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-003204
Sponsor Protocol Number: 16-003204
About this study
The purpose of this study is to develop and maintain a registry of clinical data and biological specimens from patients with immune system related blood disorders, for use in future studies of disease source, diagnosis, treatment, and prognosis.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- At least 18 years of age
- Able to provide informed consent
- Has diagnosed or suspected blood disorders associated with immune cytopenia (primary or secondary) including, though not restricted, to the following better-defined diseases
- Immune hemolytic anemia
- Cold-agglutinin disease
- Evans syndrome
- Paroxysmal cold hemoglobinuria
- Warm autoimmune hemolytic anemia
- Immune neutropenia
- Immune thrombocytopenia
- Pure red cell aplasia
- Thrombotic thrombocytopenic purpura (acquired)
- Hemoglobin levels greater than 8
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Ronald Go, M.D. |
Open for enrollment |
|
More information
Publications
Publications are currently not available